Delivery Order SPE2DB20D7066-SPE2DB25FC4QV
- Not listed
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,089.54 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply...
- The Defense Logistics Agency awarded a $9,252.00 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of August 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,100.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5ML units, with completion targeted for September 3, 2025. This non-set-aside award is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a $1,625.90 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of July 30, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.52 to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order for pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product for treating ear infections. This firm fixed-price delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded transaction with no set-aside designation. The award is fulfilled from AmerisourceBergen Drug Corp's corporate office located in...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4QVDelivery Order
The Defense Logistics Agency awarded a $9,408.60 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) under a firm fixed price contract type. The award, made on September 9, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The current delivery order for the otic antibiotic-corticosteroid suspension represents a routine fulfillment within this extensive pharmaceutical prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/9/25 |